Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The interaction between CXCL10 and cytokines in chronic inflammatory arthritis.

Lee EY, Lee ZH, Song YW.

Autoimmun Rev. 2013 Mar;12(5):554-7. doi: 10.1016/j.autrev.2012.10.001. Epub 2012 Oct 22. Review.

PMID:
23092582
2.

CXCL10 and autoimmune diseases.

Lee EY, Lee ZH, Song YW.

Autoimmun Rev. 2009 Mar;8(5):379-83. doi: 10.1016/j.autrev.2008.12.002. Epub 2008 Dec 25. Review.

PMID:
19105984
3.

Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis.

Lee EY, Seo M, Juhnn YS, Kim JY, Hong YJ, Lee YJ, Lee EB, Song YW.

Arthritis Res Ther. 2011 Jun 27;13(3):R104. doi: 10.1186/ar3385.

4.

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P.

Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2. Review.

PMID:
24189283
5.

High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.

Ruschpler P, Lorenz P, Eichler W, Koczan D, Hänel C, Scholz R, Melzer C, Thiesen HJ, Stiehl P.

Arthritis Res Ther. 2003;5(5):R241-52. Epub 2003 Jun 26.

6.

CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis.

Laragione T, Brenner M, Sherry B, Gulko PS.

Arthritis Rheum. 2011 Nov;63(11):3274-83. doi: 10.1002/art.30573.

7.

The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.

Ueno A, Yamamura M, Iwahashi M, Okamoto A, Aita T, Ogawa N, Makino H.

Rheumatol Int. 2005 Jun;25(5):361-7. Epub 2004 Mar 5.

PMID:
15004722
8.

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.

Proost P, Struyf S, Loos T, Gouwy M, Schutyser E, Conings R, Ronsse I, Parmentier M, Grillet B, Opdenakker G, Balzarini J, Van Damme J.

Arthritis Res Ther. 2006;8(4):R107.

9.
10.

IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.

Mori T, Miyamoto T, Yoshida H, Asakawa M, Kawasumi M, Kobayashi T, Morioka H, Chiba K, Toyama Y, Yoshimura A.

Int Immunol. 2011 Nov;23(11):701-12. doi: 10.1093/intimm/dxr077. Epub 2011 Sep 21.

11.
12.

Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.

Chen DP, Wong CK, Leung PC, Fung KP, Lau CB, Lau CP, Li EK, Tam LS, Lam CW.

J Ethnopharmacol. 2011 Sep 1;137(1):457-68. doi: 10.1016/j.jep.2011.05.048. Epub 2011 Jun 6.

PMID:
21679760
13.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

14.

TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.

Dharmapatni AA, Smith MD, Crotti TN, Holding CA, Vincent C, Weedon HM, Zannettino AC, Zheng TS, Findlay DM, Atkins GJ, Haynes DR.

Arthritis Res Ther. 2011 Mar 24;13(2):R51. doi: 10.1186/ar3294.

15.

Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5.

Yoshida S, Arakawa F, Higuchi F, Ishibashi Y, Goto M, Sugita Y, Nomura Y, Niino D, Shimizu K, Aoki R, Hashikawa K, Kimura Y, Yasuda K, Tashiro K, Kuhara S, Nagata K, Ohshima K.

Scand J Rheumatol. 2012 May;41(3):170-9. doi: 10.3109/03009742.2011.623137. Epub 2012 Mar 9.

17.

Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis.

Hammaker D, Boyle DL, Firestein GS.

Rheumatology (Oxford). 2012 Apr;51(4):610-8. doi: 10.1093/rheumatology/ker154. Epub 2011 May 25.

18.
19.

Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis.

Lande R, Giacomini E, Serafini B, Rosicarelli B, Sebastiani GD, Minisola G, Tarantino U, Riccieri V, Valesini G, Coccia EM.

J Immunol. 2004 Aug 15;173(4):2815-24.

Items per page

Supplemental Content

Write to the Help Desk